[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@RheumNow Dr. John Cush

Dr. John Cush posts on X about $abbv, psa, longterm, musicians the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

X Week XXXXX -XX%
X Month XXXXXX -XX%
X Months XXXXXXX -XXXX%
X Year XXXXXXX +75%

Mentions: XX #

X Months XXX +27%
X Year XXX +249%

Followers: XXXXXX #

X Week XXXXXX +0.12%
X Month XXXXXX +0.65%
X Months XXXXXX +4.40%
X Year XXXXXX +7.50%

CreatorRank: XXXXXXXXX #

Social Influence #

Social category influence stocks

Social topic influence $abbv #31, psa #351, longterm #1179, musicians, rx

Top assets mentioned AbbVie Inc (ABBV)

Top Social Posts #

Top posts by engagements in the last XX hours

"Rheumatic and musculoskeletal disorders in musicians: Famous musicians/performers with Rheumatic dz and the most common disorders reviewed"
X Link @RheumNow 2025-10-13T20:46Z 24.6K followers, 1399 engagements

"💬A JAKi CHAT: Shared Decision-Making in RA Dr. Curtis and Dr. Winthrop discuss approaches to patient conversations on risk with uncontrolled RA and treatment considerations including JAKi safety. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-09T15:30Z 24.6K followers, XXX engagements

"📊 NEW FROM EULAR: How many patients with PsA switch from their first-line treatment in the first year 📊 Explore real-world switching patterns among PsA patients on first-line advanced therapies. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-10T15:30Z 24.6K followers, XXX engagements

"Small XX pt. RCT found that 16-wks of Mediterranean diet signif improved psoriasis PASI scores. Intervention grp had better PASI change at week XX (3.4 vs 0) PASI XX and reducted hemoglobin A1c. Diet as adjunctive Rx in PsO"
X Link @RheumNow 2025-10-02T22:30Z 24.6K followers, XXX engagements

"A JAKi in RA: Explore the Data Guide 👀 Dr. Curtis and Dr. Winthrop share best practices for preparing to discuss risk in RA including a new long-term efficacy and safety data visualization tool. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-06T14:00Z 24.6K followers, XXX engagements

"NEW EULAR POSTER: Real-world treatment patterns across the first XX months of first-line advanced therapy in patients with PsA Compare treatment switching across first-line MOAs and treatments. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-07T17:00Z 24.6K followers, XXX engagements

"NEW EULAR 2025 POSTER: JAKi safety across 17000 patient-years in adults with RA PsA AS or nr-axSpA 🔍 View the long-term Phase X safety of a JAKi. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-08T14:00Z 24.6K followers, XXX engagements

"📊 NEW FROM EULAR: Real-world effectiveness of switching to a JAKi after first-line TNFi in PsA See how second-line treatment choices impacted TJC and SJC in patients from the Adelphi database. Poster sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-14T14:00Z 24.6K followers, XXX engagements

"📊 PRESENTED AT EULAR 2025: Long-term safety of a JAKi 📊 View safety across 17000 patient-years of data from XX Phase X trials in adult patients with RA PsA AS or nr-axSpA. This poster is sponsored by AbbVie Medical Affairs + Health Impact"
X Link @RheumNow 2025-10-01T02:42Z 24.6K followers, XXX engagements

"Fibromyalgia in PsO & PsA is linked to greater treatment complexity and shorter biologic therapy survival. Retro matched 1:4 cohort study 61K PsO& 244K controls. FM prevalence XXX% (OR 1.45). In PsA decr biologic survival (6 vs 10yrs) w/ incr switching (HR 1.82)"
X Link @RheumNow 2025-10-13T19:00Z 24.6K followers, 1671 engagements